Turkey approves China-based Sinovac vaccine's emergency use
Turkish authorities have given the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotch Ltd
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Turkish authorities have given the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotch Ltd., paving the way for the rollout for Turkey’s vaccination program starting with health care workers and other high-risk groups.
The health regulatory authority, the Turkish Medicines and Medical Devices Agency, said Wednesday it had approved the vaccine’s emergency use following examinations that lasted for 14 days.
Health Minister Fahrettin Koca said he and members of Turkey’s scientific advisory council would receive the first shots later Wednesday. The vaccination program will begin on Thursday, starting with health care workers, he said.